✦ LIBER ✦

Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease

✍ Scribed by McPherson, M E; Hutcherson, D; Olson, E; Haight, A E; Horan, J; Chiang, K-Y

Book ID: 109840968
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 369 KB
Volume: 46
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2010.60

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced Toxicity Conditioning with Busul

Reduced Toxicity Conditioning with Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children with High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD

✍ Radhakrishnan, Kavita; Geyer, Mark; Morris, Erin; Baxter-Lowe, Lee Ann; Cairo, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Comparative Outcomes of Donor Graft CD34

Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

✍ Pasquini, M. C.; Devine, S.; Mendizabal, A.; Baden, L. R.; Wingard, J. R.; Lazar 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB